QUANTUM BIOPHARMA LTD (QNTM) Stock Balance Sheet
NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 35.26M | 17.52M | 5.94M | 15.83M | 3.55M | |||
| Marketable Securities | 158.00K | N/A | N/A | N/A | N/A | |||
| Receivables | 501.00K | 161.30K | 1.55M | 736.00K | 233.50K | |||
| Inventories | N/A | 0.00 | 706.30K | N/A | N/A | |||
| Other Current Assets | 10.01M | 9.18M | 322.40K | 338.90K | 251.60K | |||
| Total Current Assets | 45.93M | 26.87M | 8.52M | 16.91M | 4.04M | |||
| Non-Current Assets | ||||||||
| PPE Net | 168.30K | 0.00 | 8.94M | 9.09M | 6.21M | |||
| Investments And Advances | 660.20K | 1.68M | 8.82M | 13.53M | N/A | |||
| Intangibles | 16.20M | 13.42M | 16.75M | N/A | N/A | |||
| Total Non-Current Assets | 17.03M | 15.10M | 34.51M | 22.62M | 6.21M | |||
| TOTAL ASSETS | 62.96M | 41.97M | 43.03M | 39.53M | 10.25M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 300.60K | 384.70K | 1.43M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 124.30K | 46.80K | 42.10K | N/A | N/A | |||
| Accrued Expenses | 4.46M | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 3.00M | 3.70M | 3.35M | N/A | 946.70K | |||
| Other Current Liabilities | 825.10K | 1.45M | 1.98M | 1.31M | 1.60K | |||
| Total Current Liabilities | 8.70M | 5.58M | 6.80M | 1.31M | 948.20K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 131.10K | 79.10K | 109.80K | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 131.10K | 79.10K | 109.90K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 8.83M | 5.66M | 6.91M | 1.31M | 948.20K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -121.02M | -85.90M | -54.51M | -16.53M | -3.14M | |||
| Additional Paid In Capital | 22.58M | 18.79M | 17.30M | 3.73M | 2.71M | |||
| Common Shares | 152.32M | 103.21M | 73.42M | 51.02M | 9.73M | |||
| Other Shareholders' Equity | 239.60K | 207.80K | -84.40K | N/A | N/A | |||
| Shares Outstanding | 622.20K | 294.80K | 7.91M | 6.85M | 6.57M | |||
| Tangible Book Value per Share | 60.96 | 77.63 | 2.45 | 5.58 | 1.41 | |||
| Total Shareholders' Equity | 54.13M | 36.31M | 36.12M | 38.22M | 9.30M | |||
| TOTAL LIABILITIES AND EQUITY | 62.96M | 41.97M | 43.03M | 39.53M | 10.25M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.04 | N/A | N/A | |||
| Current Ratio | 5.28 | 4.82 | 1.25 | 12.94 | 4.26 | |||
| Return On Assets (ROA) | -56.04% | -75.77% | -84.95% | -43.03% | -25.76% | |||
| Return On Equity (ROE) | -65.19% | -87.58% | -101.20% | -44.50% | -28.39% | |||
All data in USD , ROIC based on taxRate of 0.25